Valuation: Physiomics Plc

Market Cap 2.15M 2.88M 2.57M 2.38M 4.03M 273M 4.09M 28.59M 11.32M 143M 10.81M 10.58M 452M P/E 2025
-2.67x
P/E 2026 -2.35x
Enterprise Value 1.73M 2.32M 2.07M 1.91M 3.24M 220M 3.3M 23.03M 9.12M 115M 8.71M 8.52M 364M EV / Sales 2025
1.14x
EV / Sales 2026 1.64x
Free-Float
74.27%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Physiomics Plc

Current month-9.52%
1 month-9.52%
6 months-5.00%
Current year+66.67%
1 week 0.45
Extreme 0.45
0.5
1 month 0.45
Extreme 0.45
0.55
Current year 0.25
Extreme 0.2525
0.8
1 year 0.25
Extreme 0.2525
0.8
3 years 0.25
Extreme 0.2525
2.1
5 years 0.25
Extreme 0.2525
7.25
10 years 0.25
Extreme 0.2525
32
Manager TitleAgeSince
Director of Finance/CFO 52 -
Chief Operating Officer - 2026-06-30
Corporate Officer/Principal - 2021-08-30
Director TitleAgeSince
Director/Board Member - 2026-04-28
Chairman 53 2026-04-28
Director/Board Member - 2026-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/26 Buy

Director

3,000,000 0.6619%
7/10/26 Buy

Director

1,111,111 0.2452%
11/8/24 Buy

Chief Executive Officer

459,090 0.2259%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-68.33% 2.88M
-0.62%+4.81%-8.00%+29.42% 133B
-1.55%-0.33%-1.50%+58.19% 83.36B
-0.01%+11.85%-25.40%+0.66% 53.4B
-0.74%+8.18%+13.52%+26.14% 44.02B
+0.78%+9.51%-14.94%+28.91% 36.43B
-2.55%+13.09%-22.00%+7.46% 21.34B
+1.59%+8.17%-22.72%-26.21% 22.01B
-1.53%+4.67%-21.10%+6.03% 20.69B
-0.14%+2.34%+16.40%+69.95% 17.46B
Average -0.48%+6.64%-8.57%+13.22% 43.15B
Weighted average by Cap. -0.63%+6.37%-8.37%+27.64%

Financials

2025 2026
Net sales 834K 1.12M 996K 920K 1.56M 106M 1.59M 11.08M 4.39M 55.5M 4.19M 4.1M 175M 1.06M 1.41M 1.26M 1.16M 1.97M 134M 2.01M 14.01M 5.55M 70.2M 5.3M 5.18M 221M
Net income -415K -555K -496K -458K -777K -52.73M -790K -5.51M -2.18M -27.63M -2.08M -2.04M -87.1M -697K -932K -833K -769K -1.3M -88.51M -1.33M -9.26M -3.66M -46.37M -3.5M -3.42M -146M
Net Debt -457K -612K -546K -505K -856K -58.07M -870K -6.07M -2.4M -30.42M -2.3M -2.25M -95.91M -419K -560K -500K -462K -783K -53.16M -796K -5.56M -2.2M -27.85M -2.1M -2.06M -87.81M
Projected Income Statement - Annual - Physiomics Plc
Logo Physiomics Plc
Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.
Employees
11
Date Price Change Volume
26-10-23 GBX 0.4750 0.00% 200,001
26-10-22 GBX 0.4750 0.00% 195,895
26-10-21 GBX 0.4750 0.00% 34
26-10-20 GBX 0.4750 0.00% 971,692
26-10-19 GBX 0.4750 0.00% 1,134,827

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Physiomics Plc